CASI Pharmaceuticals, Inc. (CASIF)
0.1288
-0.01
(-7.20%)
USD |
OTCM |
Aug 25, 16:00
CASI Pharmaceuticals Shareholders Equity (Quarterly) : -37.28M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -37.28M |
| September 30, 2025 | -25.73M |
| June 30, 2025 | -20.31M |
| March 31, 2025 | -8.07M |
| December 31, 2024 | 1.851M |
| September 30, 2024 | 15.82M |
| June 30, 2024 | 11.04M |
| March 31, 2024 | 15.47M |
| December 31, 2023 | 24.16M |
| September 30, 2023 | 28.79M |
| June 30, 2023 | 32.23M |
| March 31, 2023 | 39.58M |
| December 31, 2022 | 44.57M |
| September 30, 2022 | 61.71M |
| June 30, 2022 | 66.94M |
| March 31, 2022 | 74.99M |
| December 31, 2021 | 84.50M |
| September 30, 2021 | 86.61M |
| June 30, 2021 | 94.80M |
| March 31, 2021 | 100.03M |
| December 31, 2020 | 81.54M |
| September 30, 2020 | 91.53M |
| June 30, 2020 | 63.34M |
| March 31, 2020 | 70.36M |
| December 31, 2019 | 73.00M |
| Date | Value |
|---|---|
| September 30, 2019 | 80.37M |
| June 30, 2019 | 89.04M |
| March 31, 2019 | 104.20M |
| December 31, 2018 | 109.46M |
| September 30, 2018 | 113.32M |
| June 30, 2018 | 83.52M |
| March 31, 2018 | 67.62M |
| December 31, 2017 | 38.54M |
| September 30, 2017 | 15.58M |
| June 30, 2017 | 17.03M |
| March 31, 2017 | 19.24M |
| December 31, 2016 | 20.78M |
| September 30, 2016 | 16.02M |
| June 30, 2016 | 10.02M |
| March 31, 2016 | 4.637M |
| December 31, 2015 | -6.087M |
| September 30, 2015 | -4.732M |
| June 30, 2015 | -3.449M |
| March 31, 2015 | -1.826M |
| December 31, 2014 | -0.4222M |
| September 30, 2014 | 0.8377M |
| June 30, 2014 | 12.74M |
| March 31, 2014 | 13.86M |
| December 31, 2013 | 14.94M |
| September 30, 2013 | 15.76M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.65M |
| Total Liabilities (Quarterly) | 62.93M |
| Debt to Equity Ratio | -0.7372 |
| Current Ratio | 0.2709 |
| Net Debt Paydown Yield | -9.57% |